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• Guidelines support clinicians to follow evidence-based practice; 
• Correct management of intraepithelial lesions (SIL) reduce the risk of cervical 
cancer;  






















National guidelines for management of cervical squamous intraepithelial lesion: 




Objectives: The management of women with cervical squamous intraepithelial lesions 
(SIL) is fundamental to prevention of cervical cancer in an organized cervical screening 
programme. Clinical guidance should improve quality of care and clinical effectiveness 
if developed and implemented appropriately. This survey provides an update on the 
current situation of national guidelines for management of cervical SIL among member 
countries of European Federation for Colposcopy (EFC). 
Study design: A questionnaire was sent to representatives of each member country of 
EFC. The questionnaire contained questions on: guidelines for management of cervical 
SIL of the National Societies/Associations of Colposcopy or others national 
societies/associations including the development and the consultation processes;  
guidelines for management of lower genital tract diseases;  and the regulations in each 
country for colposcopy practice. 
Results: We received responses from all 34 member countries. Thirty countries 
reported a national guideline for management of cervical SIL that were developed by, 
or in conjunction with, their national societies or associations of colposcopy. In most 
cases there was adherence to the recommended steps for guideline development: they 
were developed by a multi-disciplinary group of specialists (29 countries) and society 
members were consulted before publication (21 countries). A small number of countries 
(8) reported to have guidelines for the management of lower genital tract dysplasia (e.g. 
vulval disease) developed by other national societies. In most countries (26) the 
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colposcopists are obliged to follow the guidelines but this is regulated in only 6 
countries.  In 12 countries (35%) the colposcopists need to be certified by the national 
society of colposcopy in order to practice. 
Conclusion: There are advances in the development and provision of country specific 
guidance on the management of cervical SIL. Most EFC member countries have 
national guidelines that were developed using a clear methodology, are updated 
according to progresses in the field and are accessible online to current practitioners. 
These guidelines support colposcopists to follow evidence-based practice and provides 
understanding of best practice in guideline development and access.  
Keywords: guidelines; cervical squmaous intraepithelial lesions; management cervical 




The main role of cervical screening is to reduce the risk of cervical cancer through the 
detection and treatment of high-grade cervical squamous intraepithelial lesions (SIL) 
[1]. Treatment of SIL (previously known as cervical intraepithelial lesions) depends on 
various factors, including histological grade, size of lesion the patient’s age, fertility 
plans, other medical conditions, and last but not least, the preference of the patient [2]. 
The terminology cervical intraepithelial neoplasia (CIN) was replaced with SIL (“low-
grade” or “high-grade) in 2012 after the Lower Anogenital Squamous Terminology 
(LAST) consensus (Table 1) [3]. According to LAST project ”this terminology is 
familiar to clinicians, because it parallels the terminology of the Bethesda System 
cytologic reports [3]. However, some clinicians feel that the previous cervical 
intraepithelial neoplasia (CIN) classification with high-grade disease subdivided into 
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CIN2 and CIN3 is more clinically relevant with the advent of conservative management 
of CIN2, particularly in young women [4].  Biopsy results using SIL terminology may 
be further qualified using “intraepithelial neoplasia”.  
 
Today, clinical guidelines are the mainstay of quality assured medical practice. They 
aim to translate the best evidence into clinical practice. They should consist of 
systematically developed statements that help healthcare practitioners to diagnose, treat 
or even prevent diseases. Guidelines are usually developed by scientific societies or 
associations by consensus from a multi-disciplinary team. 
 
At the time of the survey, the EFC comprised 38 national colposcopy societies or 
associations from 34 countries in Europe and neighboring regions along with 5 
associated countries (Figure 1). The EFC aims to promote the best possible standards 
of colposcopy, cervical and lower genital tract pathology in Europe. Supporting high 
quality colposcopy services and using minimum standards of training for colposcopy 
throughout Europe are essential. The management of SIL requires a balance between 
interventions that prevent possible progression to cancer whilst avoiding overtreatment 
since some SIL lesions can spontaneously regress and excessive treatment can increase 
obstetrical morbidity. 
 
Although a set of European colposcopy standards and guidelines were developed as 
part of the Europe Against Cancer Program in 2008, many countries use their own 
guidelines or those from other countries [5-7]. These guidelines can differ in a variety 
of ways, including content, scope, and developmental process.  The aim of this paper 
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was to evaluate how guidelines for the management of SIL and lower genital tract 
disease were developed amongst EFC member countries. 
 
Material and methods 
A semi-structured questionnaire consisting of 40 questions was sent to representatives 
of each EFC member country. The principle lines of enquiry were whether there were 
agreed national guidelines for SIL management; who produced them; the guideline 
developmental process; the up-date process of the guidelines; and whether there were 
guidelines relating the management of other lower genital pre-invasive disease.  In 
addition, there was enquiry as to whether colposcopists had to be licensed or registered 
in order to practice and whether compliance with the guidelines was monitored. 
Results 
We received responses from representatives of all 34-member countries. Thirty 
countries reported having national guidelines for management of SIL (Austria, 
Belgium, Croatia, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, 
Iceland, Israel, Ireland, Italy, Latvia, Lithuania, Moldova, Norway, Poland, Portugal, 
Romania, Russia, Serbia, Slovenia, Spain, Sweden, Switzerland, The Netherlands, UK 
and Ukraine) (Table 2). In 29 countries, the guidelines were developed either by, or in 
close co-operation with, the national colposcopy society whilst in one other (Romania) 
the guideline development did not involve the EFC member society. The guidelines 
were introduced prior to 2000 in 6 countries, 7 during 2000-2009, 12 in the period 2010-
2015 and in 5 after 2015. Apart from in Iceland, they were developed by a multi-
disciplinary group.  In 13 countries, the group had representations from colposcopy, 
gynaecology, cytopathology and public health.  Five countries only had representation 
from gynaecology and colposcopy with the remainder including cytopathology but not 
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public health. Twenty-one countries were able to confirm consultation with their 
membership on the draft guidance.  Most countries reported having a process for formal 
review to ensure that they reflect current evidence at 3-8 year intervals but 9 countries 
did not. The interval for revision differs from society to society. In some countries 
(The Netherlands) they are revised periodically every year (if needed), while in 
other countries the revision is longer (5-7 years).   
Twenty two countries reported an up-date of the guideline since 2015 (Austria, 
Finland, Germany, Greece, Hungary, Iceland, Israel, Italy, Latvia, Moldova, Poland, 
Serbia, Slovenia, Spain, Sweden, Switzerland, Romania, Russia, The Netherlands, 
UK, Ukraine). 
 
Eight countries (Croatia, Estonia, Finland, Germany, Greece, Latvia, Norway and 
Spain) included guidelines for the management of vulvar diseases. 
 
In most countries (n=23) the colposcopists were expected to follow the guidelines but 
this is not regulated in all of them.  In 6 countries (Croatia, Estonia, Ireland, Russia, 
Slovenia and the UK) evidence of clinical practice is submitted to demonstrate 
compliance.  In 12 countries (Croatia, Finland, Greece, Hungary, Ireland, Italy, Latvia, 
Russia, Serbia, Slovenia, UK and Ukraine) colposcopists are certified by the national 
colposcopy society; however, only in 10 countries is certification mandatory in order 
to practice colposcopy. 
 
Discussion 
The Institute of Medicine defines clinical guidelines as “systematically developed 
statements to assist practitioner and patient decisions about appropriate health care for 
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specific clinical circumstances” [8]. They aim to promote high quality medical practice 
because they are based on the strongest available scientific evidence but availability, 
support and adherence are also necessary steps. 
 
A successful cervical screening programme requires not only accurate detection of 
cervical abnormalities but also their appropriate management. Several national and 
international bodies have developed guidelines on this issue including the World Health 
Organization (WHO), American Society of Colposcopy and Cervical Pathology 
(ASCCP), National Health Service (NHS) England.  Such recomendations provide 
guidance and local organizations can implement amendments appropriate to the local 
setting.  However, these should be well documented [9]. National guidelines are in 
general particularly important when regional variations exist in managing a condition. 
 
Our survey has found that most countries have their own guidelines. While in some 
countries they were introduced several decades ago (Austria, 1994, UK- 1997) in others 
they were quite recently developed (Hungary and Iceland 2017, Ukraine 2018, Russia 
2019). 
 
In addition to using systematic literature review methodology, guidelines need to be 
developed transparently and in such a way that all professional stakeholders are 
involved.  Key topics need to be agreed by a multidisciplinary group of relevant 
stakeholders.  We have identified that the majority of guidelines followed these 
principles although none mentioned patient or public involvement and this importance 
of such input should be highlighted for future revisions, as service users are key to 
compliance and uptake.  
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With only one exception (Iceland) the national guidelines for management of SIL were 
developed by a group of specialists. In most of the countries this was truly 
multidisciplinary. In five countries (Estonia, Latvia, Lithuania, Moldova and Russia) 
the guidelines resulted from the cooperation between gynecologists and colposcopists. 
Moreover there are countries where guidelines were developed in conjunction with 
other societies. For example, in Spain the guidelines are a consensus document written 
by all the national societies involved in cervical cancer screening. 
 
Not all representatives knew all the past details, but most countries involved interaction 
with members of the colposcopy society at the draft stage. This is essential to ensure 
ownership and future compliance of the practitioners who will be required to follow 
such advice. 
 
Earlier or international guidance tended to be produced in English but the development 
of national guidelines in that country’s language probably promotes increased usage. 
However, an English translation can be beneficial in order to make comparisons 
between EFC countries and allow other countries to access them. To this end, Austria, 
Greece, Poland, Spain also have guidelines in English, and the Finish guidelines have 
an English summary. An essential component of a successful guideline is to be 
available in an accessible format. As we work in a digital era the possibility of 
immediate accessing free the guideline on the Internet can be considered a mandatory 
step. Almost in all cases the national societies of colposcopies have these guidelines 
available on Internet so they can be downloaded. 
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Due to the rapid accumulation of evidence on new technologies and prevention 
strategies, review and updating of the current guidelines is essential. Guidelines need 
to be updated to take into account emerging evidence and this can be addressed by 
setting revision dates when the guideline committee will review new evidence. Panels 
of experts in the field should be involved to identify any changes in the interventions 
available. International associations can play an important role by giving important 
signals regarding the need for an updating process and from this starting point each 
national society can adapt and update their guidelines according to local policy and 
resources. In general, the best practice is to include a scheduled review update. 
However, this can be inflexible and can result in either a full update being performed 
prematurely (even if no new evidence appears in that period), or produced too late (in 
a rapid evolving field) [10]. Consequently, some guidelines stated that they will be 
updated whenever this is needed. Also, we need to keep in mind that if the guidelines 
are correctly produced and respect the methodology they can take time and expertise to 
produce them. Since 2015,  revision took place in 22 (73%) countries indicating that 
most countries are following best practice. 
 
Seven countries included guidelines for the management of lower genital tract dysplasia 
(e.g. vulval disease).  This important trend reflects the growing realization that the sites 
of preinvasive disease throughout lower genital tract should be considered collectively 
rather than in isolation.  
 
The colposcopy training is usually related to national medical training structure that has 
particularities for each country [11]. Our study showed that in twelve European 
countries, doctors performing colposcopy have to some form of registration by the 
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colposcopy society. Other countries have introduced methods of voluntary 
accreditation based on examination or curriculum vitae (Portugal, Spain). In most 
European countries, colposcopists are expected to follow colposcopic guidelines but 
only in 6 countries (Croatia, Estonia, Germany, Ireland, Russia, UK) require 
colposcopists to submit evidence. Also it is advisable that all national programs should 
include quality measures in their National Programs according to international quality 
measures [12]. This role in supporting or quality assuring colposcopists is a significant 
opportunity for colposcopy societies. Assessment of compliance with guidelines and 
providing feedback is best undertaken at regionally or nationally level rather than at a 
European level.  
 
According to this study national societies of colposcopy played over the years an 
important role in the development of national guidelines. The EFC, as an ‘umbrella’ 
federation,  can further support national societies by encouraging the principles of best 
practice which include membership of a multidisciplinary team, patient and society 
member engagement and requirement for review and updating. By working together 
under the umbrella of the EFC, European colposcopy societies can support each other 
with such quality improvement initiatives.  
Conclusion 
The majority of EFC member countries have developed national guidelines for 
management of SIL using a clear methodology. In most cases these are updated 
according to progresses in the field and are accessible to current practitioners.   
 





Austria: Olaf Reich: Belgium: Wiebrin Tjalma; Croatia: Drazan Butorac; Cyprus: 
Dinos Mavromoustakis???; Estonia: Terje Raud, Liis Kriisa; Finland: Maija Jakobsson; 
France: Xavier Carcopino; Georgia: Tamar Alibegashvili; Germany: Jens Quaas 
Volkmar  Kuppers, Greece: Georgios  Michail; Hungary: Robert Koiss; Iceland: 
Kristjan Oddsson; Ireland: Grainne Flannelly; Israel: Efraim Siegler; Italy: Andrea 
Ciavattini; Kosovo: Mazllom Smajli; Latvia: Kristine Pcolkina; Lithuania: Kristina 
Jariene; Macedonia: Goran Dimitrov; Moldova: Uliana Tabuica; Norway: Amelie 
Tropé; Poland: Robert Jach; Portugal: Amélia Pedro; Romania: Mihaela Grigore 
Russia: Vera Prilepskaya; Serbia: Vesna Kesic; Slovenia: Spela Smrkolj ; Spain: Marta 
del Pino; Sweden: Björn Strander; Switzerland: André Kind, Brigitte Frey Tirri; The 
Netherlands: A.M.L.D. van Haaften-de Jong; Turkey: Murat Gultekin; U.K.: Pierre 
Martin-Hirsch; Ukraine: Nataliya Volodko 
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Table 1. Comparison between dysplasia, CIN and LAST nomenclature for cervical 
squamous intraephitelial lesions. 
 
 
 Country Guidelines for 
management 
of SIL 




last time updated 
1.  Austria 
 
Yes 1994 2018 
2.  Belgium 
 
Yes  2011 2011 
3.  Croatia Yes 2012 2012 
4.  
Cyprus 
No   
5.  
Estonia 
Yes In the late 1990s 2013 
6.  
Finland 
Yes 2006 2019 
7.  
France 




Yes 2010 2010 
9.  
Germany 
Yes Many years ago 2015 
10.  
Greece 
Yes 2015 2015 
11.  
Hungary 
Yes 2017 2017 
12.  
Iceland 
Yes 2017 2017 
13.  
Ireland 
Yes 2009 2014 
14.  
Israel 
Yes 2010 2017 
15.  
Italy 
Yes 2002 2019 
16.  
Kosovo 
NO   
17.  
Latvia 
Yes 2015 2015 
18.  
Lithuania 
Yes 2004 no 
19.  
Macedonia 
No   
20.  
Moldova 
Yes 2015 2019 
21.  
Norway 
Yes 1995 2019 
22.  
Poland  
Yes 2016 2016 
23.  
Portugal 
Yes 2011 2014 
24.  
Romania  
Yes 2009 2019 
25.  
Russia 
Yes 2019 2019 
26.  
Serbia 
Yes 2013 2017 
27.  
Slovenia 
Yes 2012 2019 
28.  
Spain 
Yes 2015 2015 
29.  
Sweden  




Yes 2004 2018 
31.  
The Netherlands 
Yes 2012 2020 
32.  
Turkey 
No   
33.  
Ukraine  
Yes 2018 2019 
34.  
United Kingdom 
Yes 1997 2019/2020 
 
 
Table 2. EFC country members- information regarding the existence of national 
guidelines for management of SIL, when were introduced and updated. 
 
 
 
 
 
